MedCap AB (publ) (MCAP.ST)
SEK 359.0
(0.28%)
SEK 359.0
(0.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 327.4 Million SEK | 34.49% |
| 2022 | 237.3 Million SEK | 29.6% |
| 2021 | 186.8 Million SEK | 17.71% |
| 2020 | 147.8 Million SEK | 13.2% |
| 2019 | 129.6 Million SEK | 78.6% |
| 2018 | 70 Million SEK | 81.71% |
| 2017 | 63.06 Million SEK | 37.65% |
| 2016 | 30.97 Million SEK | -43.51% |
| 2015 | 56.03 Million SEK | 53.27% |
| 2014 | 35.8 Million SEK | -42.36% |
| 2013 | 54.04 Million SEK | 46.22% |
| 2012 | 43 Million SEK | 28.94% |
| 2011 | 34.67 Million SEK | -11.16% |
| 2010 | 37.54 Million SEK | -4.92% |
| 2009 | 21.53 Million SEK | 82.1% |
| 2008 | 8.01 Million SEK | -33.57% |
| 2007 | 6.94 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 93.5 Million SEK | -12.3% |
| 2024 Q3 | 98.9 Million SEK | 8.32% |
| 2024 Q1 | 104.1 Million SEK | -8.68% |
| 2023 Q2 | 88.6 Million SEK | 40.86% |
| 2023 Q4 | 101.6 Million SEK | 23.15% |
| 2023 Q3 | 82.5 Million SEK | -6.88% |
| 2023 Q1 | 62.9 Million SEK | -10.14% |
| 2023 FY | - SEK | 34.49% |
| 2022 Q1 | 56.4 Million SEK | -12.56% |
| 2022 Q3 | 70.5 Million SEK | 18.49% |
| 2022 Q4 | 70 Million SEK | -0.71% |
| 2022 Q2 | 59.5 Million SEK | 5.5% |
| 2022 FY | - SEK | 29.6% |
| 2021 Q2 | 46.1 Million SEK | 13.27% |
| 2021 Q4 | 64.5 Million SEK | 25.98% |
| 2021 Q1 | 40.7 Million SEK | -20.2% |
| 2021 FY | - SEK | 17.71% |
| 2021 Q3 | 51.2 Million SEK | 11.06% |
| 2020 FY | - SEK | 13.2% |
| 2020 Q1 | 31.5 Million SEK | -7.89% |
| 2020 Q2 | 41.1 Million SEK | 30.48% |
| 2020 Q3 | 35.1 Million SEK | -14.6% |
| 2020 Q4 | 51 Million SEK | 45.3% |
| 2019 Q3 | 26.6 Million SEK | -27.12% |
| 2019 Q4 | 34.2 Million SEK | 28.57% |
| 2019 Q1 | 41 Million SEK | 146.99% |
| 2019 Q2 | 36.5 Million SEK | -10.98% |
| 2019 FY | - SEK | 78.6% |
| 2018 Q3 | 20.1 Million SEK | 8.06% |
| 2018 FY | - SEK | 81.71% |
| 2018 Q1 | 22.34 Million SEK | 4568.4% |
| 2018 Q4 | 16.6 Million SEK | -17.41% |
| 2018 Q2 | 18.6 Million SEK | -16.75% |
| 2017 Q3 | 17.13 Million SEK | 24.82% |
| 2017 Q4 | -500 Thousand SEK | -102.92% |
| 2017 FY | - SEK | 37.65% |
| 2017 Q1 | 8.03 Million SEK | 17.83% |
| 2017 Q2 | 13.72 Million SEK | 70.82% |
| 2016 FY | - SEK | -43.51% |
| 2016 Q4 | 6.81 Million SEK | 6.75% |
| 2016 Q3 | 6.38 Million SEK | -34.39% |
| 2016 Q2 | 9.73 Million SEK | -40.27% |
| 2016 Q1 | 16.3 Million SEK | 45.63% |
| 2015 Q3 | 18.3 Million SEK | 88.89% |
| 2015 Q4 | 11.19 Million SEK | -38.83% |
| 2015 FY | - SEK | 53.27% |
| 2015 Q1 | 12.74 Million SEK | 64.49% |
| 2015 Q2 | 9.68 Million SEK | -24.0% |
| 2014 Q3 | 4.34 Million SEK | -63.1% |
| 2014 FY | - SEK | -42.36% |
| 2014 Q1 | 9.15 Million SEK | -46.56% |
| 2014 Q2 | 11.77 Million SEK | 28.63% |
| 2014 Q4 | 7.75 Million SEK | 78.37% |
| 2013 Q2 | 11.85 Million SEK | 40.35% |
| 2013 FY | - SEK | 46.22% |
| 2013 Q4 | 17.13 Million SEK | 7.72% |
| 2013 Q3 | 15.9 Million SEK | 34.14% |
| 2013 Q1 | 8.44 Million SEK | 7.92% |
| 2012 Q1 | 11.95 Million SEK | 88.98% |
| 2012 Q4 | 7.82 Million SEK | -64.11% |
| 2012 FY | - SEK | 28.94% |
| 2012 Q3 | 21.8 Million SEK | 212.84% |
| 2012 Q2 | 6.97 Million SEK | -41.69% |
| 2011 Q1 | 11.08 Million SEK | 102.91% |
| 2011 Q3 | 6.43 Million SEK | -25.49% |
| 2011 Q2 | 8.63 Million SEK | -22.1% |
| 2011 FY | - SEK | -11.16% |
| 2011 Q4 | 6.32 Million SEK | -1.71% |
| 2010 Q2 | 10.87 Million SEK | -36.32% |
| 2010 Q3 | 12.64 Million SEK | 16.29% |
| 2010 Q4 | 5.46 Million SEK | -56.77% |
| 2010 FY | - SEK | -4.92% |
| 2010 Q1 | 17.07 Million SEK | 147.49% |
| 2009 Q1 | 9.83 Million SEK | 308.39% |
| 2009 FY | - SEK | 82.1% |
| 2009 Q4 | 6.89 Million SEK | 572.14% |
| 2009 Q3 | -1.46 Million SEK | -119.92% |
| 2009 Q2 | 7.33 Million SEK | -25.43% |
| 2008 FY | - SEK | -33.57% |
| 2008 Q1 | 10.7 Million SEK | 86.21% |
| 2008 Q4 | 2.4 Million SEK | 0.0% |
| 2007 FY | - SEK | 0.0% |
| 2007 Q4 | 5.75 Million SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Athanase Innovation AB | -63.2 Million SEK | 618.005% |
| Bure Equity AB (publ) | 4.73 Billion SEK | 93.087% |
| Case Group AB (publ) | 3.41 Million SEK | -9475.899% |
| Catella AB (publ) | -60 Million SEK | 645.667% |
| Catella AB (publ) | -60 Million SEK | 645.667% |
| Creades AB | 524 Million SEK | 37.519% |
| Effnetplattformen Holding AB (publ) | 1.98 Million SEK | -16368.813% |
| First Venture Sweden AB (publ) | -17.3 Million SEK | 1991.502% |
| Flat Capital AB (publ) | -85.51 Million SEK | 482.848% |
| Hilbert Group AB (publ) | -33.24 Million SEK | 1084.91% |
| Idun Industrier AB (publ) | 339.21 Million SEK | 3.484% |
| AB Industrivärden (publ) | 27.14 Billion SEK | 98.794% |
| AB Industrivärden (publ) | 27.14 Billion SEK | 98.794% |
| Infrea AB | 98.3 Million SEK | -233.062% |
| Investor AB (publ) | 136.47 Billion SEK | 99.76% |
| Investor AB (publ) | 136.47 Billion SEK | 99.76% |
| Karnell Group AB ser. B | 267.4 Million SEK | -22.438% |
| Kinnevik AB | - SEK | -Infinity% |
| Kinnevik AB | - SEK | -Infinity% |
| Investment AB Latour (publ) | 4.23 Billion SEK | 92.275% |
| Linc AB | - SEK | -Infinity% |
| L E Lundbergföretagen AB (publ) | 9.95 Billion SEK | 96.712% |
| NAXS AB (publ) | -2.97 Million SEK | 11119.859% |
| Investment AB Öresund (publ) | 229.94 Million SEK | -42.382% |
| Ratos AB (publ) | 3.99 Billion SEK | 91.801% |
| Ratos AB (publ) | 3.99 Billion SEK | 91.801% |
| Seafire AB (publ) | 113 Million SEK | -189.735% |
| Storskogen Group AB (publ) | 3.68 Billion SEK | 91.113% |
| Stockwik Förvaltning AB (publ) | 77.9 Million SEK | -320.282% |
| Svolder AB (publ) | 149.78 Million SEK | -118.587% |
| Svolder AB (publ) | 149.78 Million SEK | -118.587% |
| AB Traction | - SEK | -Infinity% |
| Västra Hamnen Corporate Finance AB (publ) | 4.17 Million SEK | -7741.916% |
| Vo2 Cap Holding AB (publ) | 32.22 Million SEK | -916.013% |